Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Study to Investigate the Efficacy and Safety of SYR-322 When Used in Combination With Insulin Preparation in Subjects With Type 2 Diabetes in Japan

NCT01521962 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01521962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01521962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Study to Investigate the Efficacy and Safety of SYR-322 When Used in Combination With Insulin Preparation in Subjects With Type 2 Diabetes in Japan
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2012
Completion date
March 31, 2013
Enrollment
67 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus